Open access
167
Views
35
CrossRef citations to date
0
Altmetric
Review
Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma
Michael D Jain1 Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA;2 Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA
, Christina A Bachmeier3 Department of Pharmacy, Moffitt Cancer Center, Tampa, FL, USA
, Vania H Phuoc2 Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA
& Julio C Chavez2 Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA;4 Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USACorrespondence[email protected]
Pages 1007-1017
|
Published online: 31 May 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.